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Transgene of MIF induces podocyte injury and progressive
mesangial sclerosis in the mouse kidney.
Background. Recent evidence suggests that macrophage mi-
gration inhibitory factor (MIF) is a proinflammatory cytokine
that plays a pathogenic role in glomerulonephritis. Renal ex-
pression of MIF is up-regulated in infiltrating and intrinsic renal
cells, which include glomerular epithelial cells. The aim of the
current study was to further clarify the role of MIF produced
by podocytes in the process of renal disease.
Methods. We generated transgenic mice carrying a murine
MIF cDNA driven by cytomegalovirus enhancer and b-actin/b-
globin promoter, a hybrid promoter transactivated in podocytes
in vivo.
Results. MIF expression was markedly up-regulated in
podocytes in neonatal and adult transgenic kidneys. A longitu-
dinal study of the MIF transgenic mice demonstrated a progres-
sive matrix increase in mesangium accompanied by collagen IV
accumulation, representing no significant glomerular cell hyper-
cellularity. The glomeruli in transgenic kidney were not accom-
panied by influx of macrophages and T cells at the early stage
of disease progression. Although a significant number of the
mice showing higher expression of MIF died from renal failure
at 8 weeks, most of them survived with significant proteinuria
and progressive renal failure. Podocytes of transgenic mice fre-
quently underwent characteristic ultrastructural changes, such
as cell flattening, contracted foot processes, and villous trans-
formation. In addition, immunohistochemical expression of
synaptopodin, an actin-associated protein distributed in differ-
entiated podocyte foot process, was significantly attenuated in
transgenic kidney.
Conclusion. Our results indicate that podocyte-expressed
MIF could induce an injury of podocytes themselves, thereby
accelerating the progression of glomerulosclerosis and leading
to end-stage renal failure.
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Macrophage migration inhibitory factor (MIF) was
originally identified as a cytokine derived from activated
T cells that inhibits macrophage migration in vitro and
promotes delayed-type hypersensitivity [1, 2]. MIF ex-
erts various biologic functions in macrophage activation
such as enhancement of tumoricidal and parasiticidal ac-
tivities [3–5]. In addition, MIF has been shown to play a
central role in exacerbation of endotoxemia; moreover, it
acts as a unique immunomodulatory molecule that over-
rides the glucocorticoid-mediated suppression of inflam-
matory and immune responses [6–8].
MIF is constitutively expressed not only in activated T
cells, but also in many tissues, such as lung, liver, spleen,
adrenal gland, skin, and kidney tissues [9]. In kidney,
MIF mRNA and protein are constitutively expressed
in some renal epithelial cells, including tubular epithe-
lial cells and glomerular parietal and visceral epithe-
lial cells (podocytes) [10–13]. During the development
of rat crescentic anti-glomerular basement membrane
(anti-GBM) glomerulonephritis (GN), MIF expression is
up-regulated by both intrinsic renal cells and infiltrating
macrophages and T cells, and these up-regulations have
been well correlated with progressive renal injury. The in-
trinsic renal cells showing marked up-regulation of MIF
expression include tubular and glomerular epithelial cells
[10]. In addition, the MIF up-regulation in these cells has
also been demonstrated in several types of human GN
[12, 13]. Together, these findings suggest that glomerular
epithelial cells are one of the major sources of MIF in
kidney, inducing macrophage and T-cell recruitment at
the site of glomerular injury. To date, although the roles
of MIF as a critical immunologic mediator of glomerular
injury via inflammatory cell infiltration have been well
documented, it has not been demonstrated whether MIF
induces damage to or dysfunction of intrinsic glomerular
cells by a mechanism that is ultimately independent of its
effect on cell recruitment.
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To further clarify the role of MIF produced by intrin-
sic renal cells in the process of kidney disease, we es-
tablished transgenic (Tg) mice carrying a murine MIF
cDNA driven by the cytomegalovirus enhancer and
b-actin/b-globin promoter, a hybrid promoter transacti-
vated in podocytes in vivo [14]. Unexpectedly, two lines of
Tg mice developed slow progression of glomerulosclero-
sis associated with the deposition of collagen IV, a major
extracellular matrix (ECM) component in the glomerular
fibrotic process, and no significant glomerular hypercellu-
larity. In addition, histologic examination demonstrated
advanced podocyte injury accompanied by decreased ex-
pression of synaptopodin, an actin that is a specific marker
for differentiated podocytes. Based on the results, we dis-
cuss the potential biologic function and pathologic role of
MIF in podocyte injury and the accelerated progression
of glomerulosclerosis.
METHODS
Materials
The following materials were obtained from com-
mercial sources. The Isogen RNA extraction kit and
3,3-diaminobenzidine (DAB) were from Wako (Osaka,
Japan); chemstrips were from AMES (Tokyo, Japan);
the urine chemistry analyzer, Clinitek 100, was from
Miles-Sankyo, Inc. (Tokyo, Japan); epoxy resin Epok812
was from Oken (Tokyo, Japan); the DNA random
primer labeling kit was from Takara (Kyoto, Japan);
[32P]dCTP was from DuPont-NEN (Boston, MA, USA);
fluroscein isothiocyanate (FITC)-conjugated goat anti-
mouse immunoglobulin (Ig)G, IgA, IgM, and C3 were
from Cappel Laboratories (Malvern, PA, USA); FITC-
conjugated donkey anti-mouse IgG, anti-rabbit IgG, and
Cy3-conjugated donkey anti-goat IgG were from Jackson
Immunoresearch Laboratories (West Grove, PA, USA);
rat monoclonal antibody against F4/80 characterizing
mouse macrophage (clone CI:A3-1) [15] was from BMA
biomedicals (Augst, Switzerland); rat monoclonal an-
tibody against Thy-1 antigens characterizing mouse
T cells [16] was from Biomeda (Foster City, CA, USA);
mouse anti-rat synaptopodin antibody (clone G1D4)
[17] was from Progen Biotechnik GmbH (Heidelberg,
Germany); rabbit and goat anti-mouse Wilms’ tumor-1
(WT-1) antibody was from Santa Cruz Biotechnology
(Santa Cruz, CA, USA); and peroxidase-conjugated rab-
bit anti-digoxigenin (DIG) antibody, swine anti-rabbit
IgG, anti-rat IgG, and anti-mouse IgG were from Dako
(Glostrup, Denmark). Proteinase K was from Sigma
Chemical Co. (St. Louis, MO, USA). Other reagents were
of analytical grade.
Antibodies
A polyclonal anti-rat MIF antibody was generated by
immunizing New Zealand White rabbits with purified re-
combinant rat MIF in our laboratory [18]. The specificity
of this antibody has been proved by Western blotting and
enzyme-linked immunosorbent assay (ELISA). The rat
monoclonal antibodies against the human collagen IV a1
chain (H11) and a2 chain (H22) were prepared using syn-
thetic peptides and characterized as previously described
[19]. These antibodies (H11 and H22) have also been re-
ported to react with mouse tissue [20].
Generation of MIF-overexpressing Tg mice
The expression of the transgene was regulated by a hy-
brid promoter composed of the cytomegalovirus (CMV)
enhancer and b-actin/b-globin promoter [14]. The cDNA
sequence used for microinjection was constructed as fol-
lows. A 441-bp mouse fragment of MIF cDNA including
the 5′-untranslated region was obtained by polymerase
chain reaction (PCR) amplification from a reverse tran-
script of mouse liver total RNA, which was cloned into
pBluescript II KS(+), and the insert was confirmed by
sequencing analysis. The cDNA was then subcloned into
pCXN2, a derivative of pCAGGS [21, 22]. The 2.7-kb
SalI-HindIII fragment was separated from the vector se-
quence and used as a transgene. This fragment contained
the CMV-IE enhancer, a modified chicken b-actin pro-
moter, the MIF cDNA, and a rabbit b-globin 3′-flanking
sequence (Fig. 1A). The transgene was microinjected into
male pronuclei of fertilized ICR mouse embryos, which
were transplanted into the oviducts of pseudopregnant
ICR mice used as foster mothers.
Founder mice, which had integrated the transgene,
were bred with mice of the same strain. The resultant
litters were analyzed by Southern blotting on DNA ex-
tracted from their tails to distinguish between Tg mice
and non-Tg mice. Both Tg and non-Tg littermates were
maintained under pathogen-free conditions. All mouse
work was performed in accordance with the guidelines for
the care and use of laboratory animals of the Hokkaido
University Graduate School of Medicine.
Analyses of urine and serum
Urinary protein was examined by spot urine samples
on chemstrips (AMES, Tokyo, Japan). The results were
measured using a Clinitek 100 urine chemistry analyzer
(Miles-Sankyo, Tokyo, Japan) and graded semiquantita-
tively from (−) to (++++) as follows: (−) negative, (±)
trace, (+) 30 mg/dL, (++) 100 mg/dL, (+++) 300 mg/dL,
(++++) 1000 mg/dL. Blood was obtained at the time of
sacrifice, and serum levels of blood urea nitrogen (BUN)
were determined at SRL, Inc. (Tokyo, Japan).
Northern blot analysis
Northern blot analysis of MIF mRNA was carried out
as previously described [23]. In brief, total RNA was
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Fig. 1. Construct of the transgene and
expression of macrophage migration in-
hibitory factor (MIF) mRNA in MIF-
overexpressing transgenic (Tg) mice. (A)
The fragment contained the cytomegalovirus
(CMV)-IE enhancer, a modified chicken
b-actin promoter, the MIF cDNA and a rab-
bit b-globin 3′-flanking sequence. GS, globin
splice acceptor; An, poly A signal. (B) North-
ern blot analysis of Tg and non-Tg mouse kid-
neys in two independent lines. The Tg kidney
shows higher levels of MIF mRNA expression
compared to the non-Tg kidney in both lines.
In comparison between the two lines, the line
2 kidney showed higher levels of MIF mRNA
expression than the line 1 kidney.
isolated from Tg and non-Tg kidneys using an Isogen
RNA extraction kit (Wako, Osaka, Japan). Ten micro-
grams of mRNA were electrophoresed in formaldehyde/
agarose gel and transferred to a nylon membrane.
The probes for mouse MIF and glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) were labeled
with [c-32P]deoxycytidine triphosphate using a DNA
random primer labeling kit (Takara, Kyoto, Japan).
Hybridization was carried out at 42◦C for 24–48 hours.
Post-hybridization washing was performed at 65◦C for
15 minutes in × 0.2 standard saline citrate (SSC) with
0.1% sodium dodecyl sulfate (SDS). Bands were visu-
alized by autoradiography on Kodak X-AR5 film, and
quantitatively analyzed using the NIH Image system
(Bethesda, MD, USA). The results were normalized by
GAPDH mRNA levels.
Histologic analyses
Kidney tissues were fixed in 10% buffered forma-
lin, paraffin-embedded, sectioned, and stained with
hematoxylin-eosin (H&E) and periodic-acid Schiff
(PAS) reagents. To quantitatively evaluate the number
of glomerular cells per area, 10 glomerular sections con-
taining both vascular and urinary poles were selected.
The cell numbers per area of the glomerular tuft were
counted and the total glomerular cell count/glomerular
cross-section was calculated. Parietal epithelial cells of
Bowman’s capsule were not included in the cell counts.
The extent of mesangial matrix increase was defined by
the presence of increased amounts of PAS-positive mate-
rial, and the severity in each section was evaluated using
a modified scoring system adopted from previous studies
[24, 25]. A minimum of 50 glomeruli in each specimen
were examined and the severity of the lesion was graded
from 0 to 3 according to the percentage of the glomeru-
lar involvement, with grade 0 representing involvement
of 0% to 5%, grade 1 involvement of 5% to 20%, grade
2 involvement of 20% to 60%, and grade 3 involvement
of more than 60%. Calculation of the mesangial matrix
expansion index was performed in the following fashion:
the number of glomeruli with a score of 1 was multiplied
by 1, the number with a score of 2 by 2, and the number
with a score of 3 by 3. These were summed and divided
by the number of glomeruli assessed, including those with
a score of 0. The slides were examined by two investiga-
tors without prior knowledge of the group, and significant
differences in the assessments of the two examiners were
resolved by examining the slides together.
For electron microscopy, samples were fixed in cold
2.5% glutaraldeyde, postfixed in 1% osmium tetroxide,
dehydrated in a graded series of ethanol, and embedded
in epoxy resin, Epok 812 (Oken, Tokyo, Japan). Semithin
sections were stained with toluidine blue and examined
by light microscopy to identify regions of the blocks con-
taining several glomeruli. Ultrathin sections were stained
with uranyl acetate and lead citrate and were examined
with a JEM 1220 (JEOL, Tokyo, Japan).
Immunohistochemistry
For immunofluorescence study on glomerular
deposition of immunoglobulins and complement
C3, unfixed frozen samples were incubated with
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FITC-conjugated goat anti-mouse IgG, IgA, IgM, and C3.
Anti-synaptopodin antibody was also applied for im-
munofluorescent study, using FITC-conjugated donkey
anti-mouse IgG as secondary antibody. The stained
sections were observed by epifluorescent microscope
Olympus BX60 (Tokyo, Japan). For double immunoflu-
orescence labeling to determine the cells overexpressing
MIF, cryosections were washed with phosphate-buffered
saline (PBS) and incubated with anti-MIF antibody
followed by incubation with anti-WT-1 antibody. The
sections were then incubated with FITC-conjugated
donkey anti-rabbit IgG and Cy3-conjugated donkey
anti-goat IgG. The slides were examined with a confocal
laser microscope (MRC 1024; BioRad, Hercules, CA,
USA).
Immunoperoxidase staining was performed on cryo-
stat sections of tissues fixed in 2% paraformaldehyde-
lysine-periodate and subjected to the following
immunohistochemical staining. After washing with
PBS, the sections were blocked with 10% bovine serum
albumin (BSA) for 60 minutes at room temperature
and subsequently incubated in a moist chamber with
the appropriate dilution of primary antibodies at 4◦C
overnight. After washing with Tris-saline buffer con-
taining 100 mmol/L NaCl and 150 mmol/L Tris-HCl,
pH 7.5, the sections were dehydrated through graded
ethanol, incubated in methanol with 0.3% H2O2 at room
temperature for 20 minutes to block endogenous per-
oxidase activity, and washed three times with Tris-saline
buffer containing 0.02% Tween 20. Then, the sections
were incubated with appropriate peroxidase-conjugated
secondary antibodies. After washing with Tris-saline
buffer containing Tween 20, sections were developed by
reactions with DAB solution containing 0.03% H2O2,
and counterstained by hematoxylin, methyl green or
PAS reagents. Negative control study was performed
by incubation of sections with non-immune mouse or
rat serum followed by incubation with the secondary
antibodies.
The intensity of staining of the glomeruli for colla-
gen IV a2(IV) chain was scored by review of the en-
tire tissue section using a semiquantitative scale: 0, no
staining; 0.5, trace staining; 1, light staining; 2, moder-
ate staining; 3, intense staining. Tubulointerstitial infil-
tration of macrophages was also determined by the num-
ber of cells stained positively with F4/80 antibody. Five
non-overlapping fields were examined under high mag-
nification (×400), and the number of positive cells was
averaged for each field (nuclei/400 × field).
In situ hybridization
In situ hybridization was performed on cryostat sec-
tions of frozen tissue by using DIG oligonucleotide
probes [26]. The 37mer oligonucleotide antisense probe
(corresponding to nucleotides 774–810) for mouse MIF
was 5′ AAGAACAGCGGTGCAGGTAAGTGGGG
CCAGGACTCAA-3′ [27]. The probe was labeled with
DIG by using a 3′-end labeling kit (Roche, Mannheim,
Germany). Briefly, fresh frozen sections were fixed in
4% paraformaldehyde in PBS at room temperature.
They were then deproteinized by HCl and digested
with proteinase K. After hybridization with the DIG-
labeled oligonucleotide probe overnight, the sections
were washed in solutions of increasing degrees of strin-
gency (from 2 × SSC to 0.5 × SSC) at 45◦C. After
washing, the DIG-labeled probe was visualized by im-
munohistochemical staining using peroxidase- conju-
gated rabbit anti-DIG antibody and swine anti-rabbit
IgG. Color was developed by reacting with DAB solu-
tion containing 0.03% H2O2. RNase pretreatment or a
competitive study with 100-fold excess amount of ho-
mologous or unrelated, unlabeled oligonucleotides was
performed to evaluate the specificity of the signals as pre-
viously described [28].
Statistical analysis
We used the chi-square test to analyze the incidence of
proteinuria. For the comparison of two sets of unpaired
data, the unpaired Student t test was performed, except
for semiquantitative data, which were analyzed by the
Mann-Whitney U test. Values of P<0.05 were considered
to indicate statistical significance.
RESULTS
Generation of transgenic mice and expression
of MIF mRNA and protein in the kidney
We used a hybrid promoter composed of the CMV
enhancer and b-actin/b-globin promoter to drive expres-
sion of the transgene (Fig. 1A). In Northern blot analy-
sis, Tg mice showed a more than 2- to 3-fold increase in
MIF mRNA expression compared with non-Tg littermate
mice in all organs tested, including the lung, liver, skin,
and brain (data not shown). Tg mice exhibited no lethal or
prominent pathologic lesions in the organs tested, except
for progressive kidney lesions shown in the present study.
In addition, general manifestations and several biochem-
ical markers in Tg mice, including body weight, blood
pressure, serum levels of cholesterol and blood sugar
were normal until the onset of renal failure. Of multi-
ple lines prepared from the same DNA construct, two
lines of Tg mice, lines 1 and 2, were selected for the
maintenance of the colonies. Although both of the lines
showed significantly higher levels of MIF mRNA expres-
sion than did their littermates, line 2 Tg mice showed
higher mRNA expression than line 1 Tg mice (Fig. 1B).
Moreover, line 2 Tg mice showed more severe renal man-
ifestations, and some of them died of renal failure by
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Fig. 2. MIF protein expression in newborn kidney from non-Tg and
Tg mice. (A) In the non-Tg kidney, weak staining for MIF is observed
in some tubular epithelial cells at lower-power view. (B) Higher-power
view of (A) shows faint glomerular expression of MIF in the non-Tg
kidney. (C) In contrast, the Tg kidney shows marked up-regulation
of MIF immunostaining in some tubular epithelium and developing
glomeruli (asterisks). (D) Higher-power view of (C) indicates intense
labeling of MIF in developing podocytes (arrows) in the Tg kidney.
8 weeks of age. The mice manifested severe wasting be-
fore death, and the renal pathology of these mice always
presented end-stage lesions; however, the mice that sur-
vived longer than 8 weeks of age lived a normal life span.
Most line 1 Tg mice presented relatively mild renal man-
ifestations and survived as long as non-Tg mice.
To define renal expression of MIF protein in Tg mice,
we performed immunohistochemical staining for MIF
protein in the kidneys of newborn and mature mice. Im-
munohistochemical study of newborn kidneys indicated
a striking difference in the staining intensity of MIF
between non-Tg and Tg mice (Fig. 2). In non-Tg new-
born mice, MIF expression was observed mainly in tubu-
lar epithelial cells (Fig. 2A). Higher magnification views
demonstrated that MIF protein was also expressed in
some podocytes and parietal epithelial cells, but its stain-
ing intensity was very weak (Fig. 2B). On the other
hand, newborn kidneys of Tg mice demonstrated no-
tably intense expression of MIF protein in developing
glomeruli and some tubular epithelium (Fig. 2C). In ad-
dition, the staining of early capillary loop-stage glomeruli
of newborns showed intense labeling in ringlike patterns
(Fig. 2D) consistent with high levels of expression by de-
veloping podocytes.
In Tg kidneys from 4 weeks of age, MIF protein con-
tinued to be intensely expressed in podocytes and some
tubular epithelial cells (Fig. 3A–C). In addition, in situ
hybridization detected a marked up-regulation of MIF
mRNA in podocytes consistent with the results of im-
munostaining (Fig. 3D–F). To confirm cellular patterns
of MIF expression in Tg mice, we examined immunos-
taining of MIF together with the podocyte marker WT-1
[29]. Cytoplasmic expression of MIF showed colocal-
Fig. 3. MIF immunohistochemistry (top panels), in situ hybridization
(middle panels), and double immunofluorescence (bottom panels) stud-
ies in glomeruli from non-Tg and Tg mice at 4 weeks old. (Top pan-
els). While the non-Tg kidney shows weak expression of MIF in some
glomerular and tubular epithelial cells (A), MIF protein is highly ex-
pressed in podocytes and some tubular epithelial cells in the line 1 and
line 2 Tg kidneys (B and C, respectively). In the line 1 and line2 Tg mice,
the cell types expressing MIF protein are not different, but the glomeruli
from the line 2 Tg kidney show more intense MIF expression. (Middle
panels). Weak MIF mRNA expression is found in some podocytes and
tubular epithelial cells in the non-Tg kidney (D). Marked up-regulation
of MIF mRNA by podocytes (arrows) and tubular epithelial cells is ob-
served in the Tg kidney (E). Negative control by competitive study
using the section from Tg kidney shows very low background staining
(F). (Bottom panels). Double immunofluorescence study using anti-
MIF antibody and anti-WT1 antibody in the Tg kidney. White arrows
depict Wilms’ tumor (WT)-1–positive podocytes labeled with overex-
pressed MIF in the Tg mice (G–I).
ization with nuclear expression of WT-1 in Tg kidneys
(Fig. 3G–I). In advanced stage, MIF staining in WT-
1–negative endocapillary/mesangial cells of injured
glomeruli in Tg kidneys appeared mostly around
30 weeks of age (data not shown). In the line 1 and line
2 Tg mice, the cell types expressing MIF were not dif-
ferent, but the kidney sections from line 2 Tg mice ex-
hibited more intense MIF expression than line 1 Tg mice
(Fig. 3A–C), consistent with the results of Northern blot
analysis.
Urinary and serum analysis
Urinary protein and blood urea nitrogen (BUN) were
determined at between 4 and 30 weeks of age in Tg mice
and non-Tg mice (Table 1, Fig. 4). In Tg mice, protein-
uria of more than 30 mg/dL was found in 80% of the mice,
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Table 1. Incidence of proteinuria in MIF Tg mice
Proteinuriaa
Mice −∼± + ++ +++
Non-Tg mice 3 (20%) 7 (46.7%) 5 (33.3%)
(N = 15)
Tg mice (N = 46) 1 (2.2%) 8 (17.4%) 23 (50.0%)b 14 (30.4%)b
(Lines 1 and 2)
Line 1 (N = 21) 1 (4.8%) 5 (23.8%) 13 (61.9%) 2 (9.5%)
Line 2 (N = 25) 0 (0%) 3 (12.0%) 10 (40%) 12 (45.0%)c
Mice were 4 to 30 weeks old.
aSemiquantitative analysis: (−) negative; (±) trace; (+) 30 mg/dL; (++) 100
mg/dL; (+++) 300 mg/dL.
bThe incidence of proteinuria of more than 30 mg/dL was significantly high in
Tg mice (P < 0.01, compared with non-Tg mice).
cSignificant number of line 2 Tg mice showed severe proteinuria of more than
100 mg/dL (P < 0.05, compared with line 1 Tg mice).
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Fig. 4. Levels of blood urea nitrogen in MIF Tg mice from 4 to
30 weeks of age. Horizontal bars indicate average levels: N = 21–25
for each group. ∗P < 0.001 between line 2 Tg and non-Tg mice. The
levels in line 1 Tg mice show a trend toward elevation compared with
non-Tg mice, but the difference is not significant.
and severe proteinuria of more than 100 mg/dL was ob-
served in 30% of the mice. By contrast, 30% of non-Tg
mice showed proteinuria of more than 30 mg/dL, and
proteinuria of more than 100 mg/dL was not detected. In
comparison between the two lines, line 2 Tg mice showed
severe proteinuria of more than 100 mg/dL more fre-
quently (48%) than line 1 Tg mice (9.5%). These dif-
ferences in the incidence of proteinuria were statistically
significant (Table 1). Blood urea nitrogen was signifi-
cantly elevated in line 2 Tg mice (44.7 ± 15.0 mg/dL;
mean ± SD) compared with non-Tg mice (23.9 ± 4.4 mg/
dL) (P < 0.001). Line 1 Tg mice also displayed increased
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Fig. 5. Renal histologic features (upper panels) and semiquantitative
analysis of glomerulosclerosis (lower panel) in non-Tg and Tg mice.
(Upper panels). Period-acid Schiff (PAS)-stained sections of a non-Tg
mouse (A), a line 2 Tg mouse at 2 weeks of age (B), and a 30-week-old
line 2 Tg mouse (C). (Lower panel). Sclerosis index in Tg mice (D). ,
Non-Tg; , Line 1 Tg; , Line 2 Tg. Bars indicate SD; N = 5 mice from
each experimental group. ∗P < 0.01, ∗∗P < 0.05 between Tg and non-Tg
mice.
BUN levels (30.4 ± 10.9 mg/dL) compared with non-Tg
mice, though the difference was not statistically signifi-
cant (Fig. 4).
Light microscopic studies
The renal histology of line 2 Tg mice was normal in
the neonatal period, but glomerular pathologic changes
appeared as early as 2 weeks of age. The glomeruli dis-
played an expanded mesangium, leading to obliteration
of capillaries in severe lesions (Fig. 5A and B). The ex-
panded mesangium consisted of increased amounts of
PAS-positive extracellular matrix (ECM) materials. The
tubulointerstitial region appeared normal at this age and
showed no cell infiltration, tubular atrophy, or intersti-
tial fibrosis. The line 2 Tg mice that survived longer
than 4 weeks of age showed slowly progressive mesan-
gial sclerosis, which became prominent at 30 weeks of
age (Fig. 5C). The glomeruli showed increased amounts
of PAS-positive material and frequently exhibited lob-
ular patterns of glomerular tufts. In addition, thicken-
ing or wrinkling of glomerular capillary loops was often
seen. Mononuclear cell infiltration was not prominent
Sasaki et al: Podocyte injury and glomerulosclerosis by MIF 475
Table 2. Glomerular cell number and sclerosis index in MIF Tg micea
Tg mice
Non-Tg mice Line 1 Line 2
Glomerular cell number 45.1 ± 1.86 45.3 ± 3.56 44.0 ± 2.33
Sclerosis index 0.65 ± 0.27 1.19 ± 0.24b 2.10 ± 0.24c
aValues are expressed as mean ± SD.
bP < 0.05, compared with non-Tg mice.
cP < 0.01, compared with non-Tg mice.
in glomeruli or the interstitium, even with the progres-
sion of glomerulosclerosis. On the other hand, line 1 Tg
mice showed qualitatively similar glomerular lesions that
consisted of an expanded mesangium, but the severity
was milder than that of line 2 Tg mice. Immunofluores-
cence studies of non-Tg and Tg mice were performed
to examine deposition of immunoglobulins and C3 (data
not shown). By 8 weeks of age, glomeruli in both Tg
and non-Tg mice showed trace deposition of IgG, IgA,
IgM, and C3, with the exception that line 2 Tg mice
with rapid progression of renal lesions showed increased
amounts of IgG, IgA, IgM, and C3 in severely sclerosed
glomeruli. The frequency of the glomerular deposition of
immunoglobulins and C3 gradually increased with age in
both Tg (lines 1 and 2) and non-Tg mice, and no signifi-
cant difference was found between them.
To further evaluate the glomerular pathology seen in
Tg mice, a glomerular cell count and semiquantitation of
mesangial sclerosis were done in 20- to 30-week-old mice
(N = 5) (Table 2). The number of glomerular cells was not
different among non-Tg mice, line 1 and line 2 Tg mice,
45.1 ± 1.86, 45.3 ± 3.56, and 44.0 ± 2.33, respectively.
Glomerular sclerosis was classified using 4 grades (grades
0–3), and the sclerosis grade was significantly higher in
line 2 (2.10 ± 0.24) and line 1 (1.19 ± 0.24) Tg mice than
in non-Tg mice (0.65 ± 0.27) (Fig. 5D). Semiquantitative
data also indicated that the glomeruli in Tg mice pre-
sented progressive mesangial sclerosis without hypercel-
lularity, and that the glomerulosclerosis was more severe
in line 2 Tg mice than in line 1 Tg mice.
Ultrastructure studies
Ultrastructural examination of the kidneys of line 2 Tg
mice showed abnormalities as early as 2 weeks of age
compared with non-Tg mice (Fig. 6A and B). The abnor-
malities in these young Tg mice consisted of an extremely
expanded mesangium with an increase of extracellular
material. The podocytes were flattened and the capil-
lary lumen was mostly obliterated with an extensively ex-
panded mesangium. At this age, podocyte foot processes
were well-preserved and the glomerular basement mem-
brane (GBM) was almost intact. Mice surviving longer
than 8 weeks of age with slow progression of renal man-
ifestations also showed an expanded mesangium with
Fig. 6. Ultrastructural analysis of a glomerulus from non-Tg (left pan-
els) and Tg (right panels) mice. (A) A two-week-old non-Tg mouse
with normal glomerular ultrastructure. (B) A two-week-old Tg mouse
with renal failure, showing an expanded mesangium occluding the cap-
illary lumen (asterisks) and flattened podocytes. (C) A thirty-week-old
non-Tg mouse with normal glomerular structure. (D) A thirty-week-
old Tg mouse with accelerated renal failure, showing severely sclerotic
lesions with irregularity of the GBM (arrows). Electron-dense deposits
were rarely observed. (E) Ultrastructural findings of a podocyte from
a non-Tg kidney at 4 weeks of age. Note the regular arrangement of
delicate podocyte foot processes (arrows) attached to the GBM around
the periphery of the capillary. (F) A podocyte from the Tg kidney at
4 weeks of age. In contrast to the delicate arrangement of foot pro-
cesses in the non-Tg kidney, the foot processes have retracted, spread
out, and effaced along the GBM. Note that the podocyte surfaces fac-
ing the urinary space underwent (arrowheads) villous transformation
(asterisks). Pod; podocyte, BC; Bowman’s capsule, GBM; glomerular
basement membrane, Scale bars, 1 lm.
accumulation of extracellular material, and a segmental
GBM wrinkling (Fig. 6C and D). The podocyte foot pro-
cesses were entirely effaced in such glomeruli. Electron-
dense deposits usually observed in immune-complex
mediated GN were not well defined. Glomeruli from line
1 Tg mice also showed similar changes, but each abnor-
mality was milder than that of line 2 Tg mice.
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Fig. 7. Identification of macrophages and T cells in glomeruli of Tg
and non-Tg mice at 4 weeks old (upper panels) and 30 weeks old (lower
panels). (Upper panels). Note that no significant infiltration of F4/80
positive cells (macrophages) and Thy-1–positive cells (T cells) is ob-
served in the glomeruli showing an expanded mesangium in the Tg
mice (A–F). In the interstitium, lower magnification of view shows no
significant difference in macrophage infiltration between the non-Tg
and Tg kidneys (A, D). Periglomerular infiltration was rarely observed
in the Tg kidney (E, F). (Lower panels). After 30 weeks of age, a few
infiltrating F4/80 or Thy-1–positive cells appear in some glomeruli of
Tg mice (G–L).
In ultrastructural examination using a high-power view
(Fig. 6E and F), the podocytes in non-collapsed glomeruli
in Tg mice frequently showed characteristic findings.
While the podocytes in the non-Tg kidney have fine foot
processes that cover entire GBM (Fig. 6E), the podocytes
in the Tg kidney frequently contracted and showed ef-
faced foot processes with villous transformation at the
apical portion of the cells (Fig. 6F).
Inflammatory cell infiltration
Infiltration of macrophages and T cells in the kidneys
of non-Tg and Tg mice was investigated by immunohis-
tochemistry. At 4 weeks old, no significant infiltration
of macrophages and T cells was observed in glomeruli
from Tg kidneys, even with the presence of mesangial
expansion (Fig. 7A–F). In addition, the extent of tubu-
lointerstitial infiltration of inflammatory cells in Tg kid-
neys did not differ from non-Tg kidneys (Fig. 7A and
D), wheareas periglomerular infiltration existed on rare
occasions (Fig. 7E and F). By quantitative analysis, the
number of macrophages positive for F4/80 antibody was
not increased in line 2 Tg kidneys than non-Tg kidneys:
42.2 ± 9.3/400 × field versus 38.9 ± 7.8/400 × field, respec-
tively (N = 6). At advanced stage, influx of macrophages
and T cells developed in some glomeruli from Tg kidneys
around 30 weeks of age, but the extent of infiltration was
mild (Fig. 7G–L).
Glomerular collagen IV protein deposition
Collagen IV a1 and a2 chains are major ECM com-
ponents in normal glomeruli, and distribute in the
mesangium and subendothelial region of GBM. To an-
alyze prominent expansion of mesangium in Tg mice, we
performed immunohistochemistry using specific antibod-
ies against these chains. The immunostaining revealed a
significant increase in collagen IV expression in the ex-
panded mesangium of Tg mice at 4 to 30 weeks of age
(Fig. 8A–D). Using a semiquantitative scoring method
for the staining intensity of the collagen IV a2 chain, the
mean staining intensity was significantly increased in line
2 and line 1 Tg mice compared with non-Tg mice (P <
0.01): 1.64 ± 0.23 and 1.21 ± 0.27 versus 0.77 ± 0.18, re-
spectively (N = 8) (Fig. 8E). In the line 1 and line 2 Tg
mice, line 2 Tg mice showed a significant increase in in-
tensity compared with line 1 mice (P < 0.05) (Fig. 8E).
Expression of podocyte-specific markers
To define the extent of podocyte injury, which may un-
derlie glomerular degeneration in MIF Tg mice, immuno-
histochemical analysis of two specific podocyte markers,
synaptopodin and WT-1, was performed in non-Tg and
Tg kidneys.
Synaptopodin is present in the completely differenti-
ated podocyte and modulates the actin-based shape and
motility of the podocyte foot processes [17]. In non-Tg
mice in the present study, synaptopodin expression was
intense and showed fine granuation that occurred linearly
along GBM (Fig. 9A, C, and E). In contrast, synaptopodin
expression in Tg mice with renal failure was frequently
attenuated or partly diminished over segmentally obliter-
ated lesions, and the linear expression changed to a more
segmental pattern with marked interruption and coarse
granuations (Fig. 9B, D, and F).
Non-collapsed glomeruli in proteinuric Tg mice also
demonstrated global attenuation of synaptopodin im-
munoreactivity in the podocyte foot processes over in-
tact GBM compared with the glomeruli in non-Tg mice
(Fig. 10A and B). In contrast to synaptopodin expres-
sion, immunolabeling for WT-1, another specific marker
protein expressed at nuclei in mature podocytes [29], in
serial sections showed no significant difference between
non-Tg and Tg mice (Fig. 10C and D). These findings
suggest that reduction of synaptopodin expression in Tg
mice is not the result of podocyte dissapearance, and that
dysfunction of the podocyte cytoskeletal system may pre-
cede accelerated glomerulosclerosis in Tg mice [30, 31].
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Fig. 8. Collagen IV a 1 and a 2 expression in kidneys of Tg and non-Tg
mice. (A–D) Immunoperoxidase staining of kidney sections from non-
Tg and line 2 Tg mice stained for collagen IV a1 (A, C) and a2 (B, D)
chains. (E) Intensity of glomerular staining for collagen IV a2 chain. ,
Non-Tg; , Line 1Tg; , Line 2 Tg mice. Bars indicate SD. N = 8 mice
from each experimental group. ∗P < 0.01 between Tg and non-Tg mice;
∗∗P < 0.05 between line 1 Tg and line 2 Tg mice.
DISCUSSION
In the present study, we demonstrated the devel-
opment of renal lesions in Tg mice with high ex-
pression of MIF mRNA and MIF protein under the
control of a hybrid promoter consisting of CMV en-
hancer and b-actin/b-globin promoter elements. These
mice showed significantly increased levels of protein-
uria and azotemia. Immunohistochemistry and in situ hy-
bridization revealed that renal expression of MIF was
convincingly up-regulated in the kidneys of Tg mice, and
the glomerular pathology consisted of progressive mesan-
gial sclerosis with increased collagen IV accumulation
without a significant increase in glomerular cells.
Fig. 9. Alterations of synaptopodin expression in glomeruli of Tg in
renal failure and non-Tg mice at 24 weeks of age. Immunofluorescence
staining at a low-power view (A, B) and at a high-power view (C, D)
shows intense and global expression of synaptopodin in all glomeruli in
the non-Tg kidney, whereas the expression in the Tg kidney is sparse in
distribution and markedly attenuated (white arrows). Immunoperoxi-
dase staining in the non-Tg (E) and Tg (F) kidney demonstrated partly
diminished staining of synaptopodin in podocytes over sclerosed tufts
(arrowheads) and substantial attenuation of staining in other podocytes
over intact tufts in the Tg kidney (F).
Recent reports have suggested that MIF can be pro-
duced by intrinsic renal cells and plays significant patho-
physiologic roles in kidney disease. In normal rat and
human mature kidneys, we, and others, have reported that
MIF is expressed in a small number of podocytes, pari-
etal epithelial cells and tubular epithelial cells [11–13, 32].
Moreover, the pathologic roles of MIF in kidney disease
have been extensively studied in experimental and hu-
man GN [10, 12, 13, 32–34]. Using a model of rat crescen-
tic anti-GBM GN, Lan et al [10] first demonstrated that
glomerular expression of MIF mRNA and MIF protein
is markedly up-regulated in intrinsic renal cells, includ-
ing glomerular epithelial cells. They also demonstrated
that glomerular MIF expression is markedly up-regulated
in human proliferative GN, such as IgA nephropathy,
mesangiocapillary GN and focal segmental glomeru-
losclerosis, and that up-regulation of MIF expression is
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Fig. 10. Synaptopodin and Wilms’ tumor (WT)-1 expression in serial
sections from the same glomeruli of Tg and non-Tg mice at 4 weeks
of age. Serial sections from non-Tg and proteinuric Tg kidneys were
stained with antibodies specific for two podocyte markers, synaptopodin
and WT-1. Synaptopodin expression in the podocyte foot processes in
the Tg kidney was globally attenuated (A, B), whereas nuclear staining
of WT-1 protein was well preserved in podocytes in both the non-Tg
and Tg kidney (C, D).
seen in intrinsic glomerular cells, including endothelial
and epithelial cells [12]. Interestingly, they also found that
there is an increase in MIF expression in membranous
nephropathy, non-proliferative GN that is not accompa-
nied by inflammatory cell infiltration. These studies indi-
cated that podocytes might be a potential source of MIF at
the constitutional and pathologic stage in glomeruli. Al-
though these studies have suggested that MIF plays a role
in proliferative lesions of GN through the recruitment of
inflammatory cells at the sites of injury, it is poorly under-
stood if MIF plays a role in the process of glomeruloscle-
rosis that is ultimately independent of its effect on cell
recruitment. In the present study, the glomerular pathol-
ogy in Tg mice revealed that overexpression of MIF by
podocytes might enhance mesangial matrix accumulation
without any effect on monocyte recruitment.
Immunohistochemistry and in situ hybridization in
neonatal Tg kidneys demonstrated that MIF expression
was markedly up-regulated in almost all podocytes in de-
veloping glomeruli and in some tubular epithelial cells.
MIF protein expression in podocytes continued to be
up-regulated until the mature stage, with progression
of mesangial sclerosis. Akagi et al [14] have recently
found that a green fluorescent protein and the human
CD4 cDNA driven by the hybrid promoter used in the
present study are expressed only in glomeruli, and mainly
in podocytes. They suggested that this hybrid promoter
might have a podocyte-specific enhancer element, and
might induce strong selective expression in podocytes
in vivo [35]. The up-regulation of MIF expression in
podocytes in the kidneys of Tg mice may be induced by
this hybrid promoter, and by amplification of its own con-
stitutive expression through overproduction of MIF in
these cells in an autocrine manner. Because MIF expres-
sion is up-regulated in glomerular epithelial cells at many
pathologic stages in kidney disease, the MIF Tg mice used
in the present study may be a suitable model for explor-
ing the roles of podocyte-expressed MIF in the process
of glomerular disease.
Progressive mesangial expansion in the kidneys of Tg
mice appeared as early as 2 weeks of age, as demonstrated
by light microscopic and ultrastructural examinations, but
its progression was relatively slow. Although some line
2 Tg mice exhibited rapid progression of glomeruloscle-
rosis and died of renal failure by 8 weeks of age, most
line 1 Tg mice and some line 2 Tg mice survived longer
than 8 weeks of age—indeed, most lived to at least
40 weeks of age. The pathologic glomerular abnormalities
in both lines of Tg mice were similar in appearance, even
though line 1 Tg mice showed relatively mild renal le-
sions. Glomerular cell count in Tg mice did not differ from
non-Tg mice, whereas semiquantitative analysis showed
a significant increase of the sclerosis index in the kidneys
of both line 1 and line 2 Tg mice in comparison with non-
Tg mice. Taken together with the results of Northern blot
and immunohistochemical analysis, which showed higher
MIF expression in line 2 than in line 1 Tg kidneys, these
findings demonstrate that progressive glomerulosclerosis
in these two independent mice lines could be associated
with overexpressed MIF in podocytes.
By immunohistochemistry, we showed that mesangial
expansion was not accompanied by glomerular infiltra-
tion of macrophages and T cells at the early stage of
disease around 4 weeks of age. Influx of inflammatory
cells into some glomeruli appeared in older mice around
30 weeks of age. These results suggest that progressive
mesangial expansion in Tg kidneys was not caused pri-
marily by inflammatory cell infiltration at least until the
later stage, when the infiltration of these cells in kidney
may participate in disease progression [36]. On the con-
trary, immunostaining of collagen IV a1 and a2 chains,
the major ECM components increased in progressive
glomerulosclerosis [37, 38], showed an increase in stain-
ing intensity in the mesangium of Tg kidneys from the
early stage of disease progression. In addition, the scores
of collagen IV staining intensity were significantly higher
in line 2 Tg mice than that of line 1 Tg mice. These data
suggest that overexpressed MIF in podocytes in Tg mice
could enhance an increase in the mesangial matrix via
accumulation of collagen IV, suggesting this functional
disturbance may represent an initial event from which
all subsequent mesangial sclerosis and progressive renal
failure might result.
The podocytes, highly differentiated cells that cover the
outer surface of the glomerular capillary tuft, are the tar-
get for injury in many forms of human and experimental
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glomerular disease [39, 40]. Recently, some reports have
suggested that mesangial alterations might be caused by
the primary damage of the podocytes [41, 42]. In MIF
Tg mice, overexpression of MIF in podocytes was ob-
served from the neonatal period, subsequently showing
characteristic morphologic alterations of podocyte ar-
chitecture, such as cell flattening, foot process efface-
ment, and microvilli formation, as well as decreased
immunohistochemical expression of synaptopodin, a
representative podocyte-specific marker that is inti-
mately associated with actin filaments present in the
foot process [17]. Synaptopodin expression in Tg kidneys
was significantly attenuated in the podocytes over intact
GBM, or diminished in the podocytes over tufts obliter-
ated due to sclerosis. In addition, serial glomerular sec-
tions from Tg mice continued to show immunoreactivity
for WT-1, another podocyte marker that distributes in
the nuclei, although synaptopodin expression was much
attenuated in the same glomeruli. Changes of podocyte
differentiation marker expression have been reported in
several glomerular diseases, such as minimal change dis-
ease, idiopathic focal segmental glomerulosclerosis, and
HIV-associated nephropathy [30, 31, 43]. These reports
suggest that a loss or attenuation of synaptopodin ex-
pression preceding progressive glomerulosclerosis is fre-
quently observed in kidney diseases, the pathophysiology
of which may include podocytes as a primary target. To-
gether with morphologic alterations of podocyte archi-
tecture in young Tg kidneys, a decrease in synaptopodin
expression in the Tg kidney may result from primary
podocyte damage—that is, from a dysregulated podocyte
phenotype caused by overexpressed MIF—rather than
from the loss of podocytes due to severe mesangial
sclerosis.
MIF, a pleiotrophic lymphocyte and macrophage cy-
tokine, is considered to play a critical role at the pin-
nacle of the cytokine network with the wide range of
actions, including release of chemokines and other cy-
tokines [8]. As in the case of MIF, two other major proin-
flammatory cytokines, interleukin-1b (IL-b) and tumor
necrosis factor-a (TNF-a) have been reported to be ex-
pressed at podocytes in several types of GN [44, 45] and
to induce certain alterations of podocyte behavior, in-
cluding excess ECM synthesis and the actin cytoskeleton
reorganization [46–48]. Moreover, supportive of a piv-
otal role for proinflammatory cytokines in induction of
podocyte injury is the recent observation that both of
these cytokines up-regulated expression of nephrin, a slit
diaphragm protein responsible for glomerular filtration
barrier function in human podocytes [49]. In addition to
the properties as a proinflammatory cytokine, MIF ex-
hibits a number of unusual properties, which include in-
tracellular action to modulate the cell cycle regulation
[50]. In conjunction with these studies, our observations in
MIF Tg mice may suggest that podocyte-expressed MIF
can effect podocyte functionality and participate in the
acceleration of chronic podocyte injury, resulting in pro-
gressive glomerulosclerosis.
Other plausible explanations of progressive glomeru-
losclerosis in Tg mice, apart from the direct contribution
of podocyte-expressed MIF in causing chronic podocyte
injury, should be considered. In MIF Tg mice, overex-
pressed MIF derived from systemic circulation or through
retrograde diffusion from podocytes could lead to sys-
temic organ injuries through its proinflammatory effect.
In Tg mice, however, no lethal or prominent pathologic
lesions caused by a proinflammatory action of overex-
pressed MIF were observed in other organs including
lung, liver, skin, and brain. In this respect, we must con-
sider that an inflammatory spectrum of action of MIF
shows a bell-shaped dose-response profile and the down-
regulation of responses may occur at high concentra-
tion of MIF [51]. In addition, Tesch et al [34] have
suggested that exposure of cultured mesangial cells to
exogenous MIF does not lead to cell proliferation, or up-
regulation of transforming growth factor-b1 and mono-
cyte chemoattractant protein-1. However, the role of
cytokines in disease is contextual and depends on a wide
variety of factors, including interactions among other
growth factors or cytokines that can act both synergisti-
cally and antagonistically with respect to one another, and
on cell type and environment [52, 53]. Based on our ob-
servations in MIF Tg mice, the in vitro relevance of MIF
to glomerular cell behaviors still needs to be further val-
idated using characterized cultured podocytes together
with mesanigial cell lines.
CONCLUSION
Our results indicate that podocyte-expressed MIF
could induce injury of podocytes themselves, thereby ac-
celerating the progression of mesangial sclerosis. Because
podocytes have been considered to be a primary target
in various glomerular diseases, analysis of MIF Tg mice
offers new insights into the mechanisms of glomeruloscle-
rosis by MIF-induced podocyte damage, as well as explo-
ration into a variety of therapeutic approaches directed
at neutralizing the effects of MIF or at decreasing its
synthesis.
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